Drugs / TTK
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00681330 | May 2008 → Apr 2009 | esophageal cancer | Tokyo University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TTK | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00681330 ↗ |
| Modality | Peptide | “TTK peptide (1mg)” NCT00681330 ↗ |